Requesting the government to provide confirmation on four critical points — exemption from price restriction, indemnification, bridging trial waiver and basic customs duty exemption,
Cipla has said such an assurance will help make this significant financial commitment of more than USD 1 billion (over Rs 7,250 crore) advance to Moderna for its booster vaccine in India, sources privy to the development said.
Professor Ravi Gupta of the University of Cambridge, who is a member of the government’s New and Emerging Respiratory Virus Threats Advisory Group (Nervtag), said although new cases were “relatively low” the B.1.617 variant of the COVID-19 had fuelled “exponential growth”, the BBC reported.
On Sunday, the UK reported more than 3,000 new COVID infections for a fifth day in a row. Prior to this, the UK had not surpassed that number since April 12.
India recorded nearly 90.3 lakh Covid cases in May, by far the highest monthly count reported in any country so far. Although infections steadily declined through the second half of the month, the numbers overall were so high that the case count in May was 30% higher than the previous record of 69.4 lakh, also reported in India in the month of April.
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.